Clinical Charts
Thromboembolic Disorder Assessment: DVT/PE
Risk factors, prevention strategies, signs & symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).
Your search for dabigatran returned 13 results
News
GI Bleed Hospitalization Risk Linked to Oral Anticoagulant Choice, PPI Cotherapy
To compare the incidence of hospitalization for upper GI tract bleeding, researchers used US Medicare beneficiary files to identify a cohort of patients that were ≥30 years old who initiated oral anticoagulation therapy with apixaban, dabigatran, rivaroxaban, or warfarin, with or without PPI cotherapy.
News
Stroke, Major Bleed Risk Compared Among Novel Oral Anticoagulants
The study analyzed data from NVAF patients newly initiating treatment with dabigatran, rivaroxaban or apixaban.
News
Impact of Oral Anticoagulants on Renal Outcomes Compared
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
News
Dosing Errors Common with Certain Blood-Thinning Medications
Study of newer medications finds 16 percent receive too much or too little
Drug News
Women More Often Treated with Low-Dose Dabigatran
Despite trend toward lower stroke risk with high dose
Drugs in the Pipeline
FDA Accepts sNDA for New Pradaxa Indication
Boehringer Ingelheim announced that the FDA has accepted for filing the supplemental New Drug Application (sNDA) for Pradaxa (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have had primary elective total hip replacement surgery.
Drug News
AAN: Anticoagulation with Nonvalvular Atrial Fibrillation
Most people with nonvalvular atrial fibrillation (NVAF) should be taking oral anticoagulants to prevent stroke.
Drug News
ESC: Complications Noted After Dabigatran Heart Valve Tx
Patients with heart valve replacements have greater rates of thromboembolic and bleeding complications after treatment with dabigatran vs. warfarin.
